Pri-Med Washington, D.C. | Medical Conference

Description

Lack of response to SSRI medications for depression is common in primary care. Several treatment “next step” options are available, including medication augmentation or switching. Further treatment options may include ketamine, transcranial magnetic stimulation and electroconvulsive therapy. Through a concise review of recent clinical guidelines and an evidence-based review, attendees will get updated on cutting edge approaches to manage these “difficult to treat” cases. Case-based discussion will be used to illustrate concepts.

Learning Objectives

• Outline second and third-line medications to manage non-response in major depression
• Discuss how neuromodulation fits into the management of difficult-to-treat depression.
• Examine augmentation strategies in difficult-to-treat depression